Melpor

Meloxicam, the active ingredient in Melpor, is a nonsteroidal anti-inflammatory drug presented as an oral tablet for oral use. It is indicated for the management of pain and inflammation associated with osteoarthritis, rheumatoid arthritis, ankylosing spondylitis, acute musculoskeletal pain, and post‑operative pain in adult patients.

GNH USA supplies Melpor as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides regulatory‑approved batches to meet global demand, with reliable logistics and comprehensive documentation.

Meloxicam is used to treat inflammatory and degenerative joint conditions by reducing pain and swelling.

Osteoarthritis: reduces joint pain and improves function. Rheumatoid arthritis: decreases inflammation and slows disease progression. Ankylosing spondylitis: alleviates spinal stiffness and pain. Acute musculoskeletal pain: provides rapid relief of pain and inflammation. Post‑operative pain: helps control pain after surgical procedures.

Meloxicam may cause a range of adverse reactions, varying from mild to serious.

Common Side Effects: - Gastrointestinal discomfort or dyspepsia - Nausea or vomiting - Headache or dizziness - Mild peripheral edema - Transient increase in blood pressure

Serious or Rare Side Effects: - Gastrointestinal ulceration or bleeding - Cardiovascular events such as myocardial infarction or stroke - Acute renal impairment or failure - Severe skin reactions (e.g., Stevens‑Johnson syndrome) - Elevated liver enzymes or hepatitis - Anaphylactic or severe allergic reactions

When prescribing meloxicam, clinicians should consider several safety measures.

Assess renal function: evaluate baseline kidney function before initiating therapy. Monitor hepatic enzymes: check liver function tests periodically. Avoid in patients with known hypersensitivity to NSAIDs: contraindicated. Use lowest effective dose: minimize risk of gastrointestinal complications. Consider gastroprotective agents: co‑prescribe a proton pump inhibitor if risk factors present. Store at ambient temperature: keep in original container, protect from moisture and direct sunlight.

Meloxicam can interact with other medicines, requiring careful management.

Major Interactions (Avoid): - Anticoagulants (e.g., warfarin): increased risk of bleeding. - Selective serotonin reuptake inhibitors (SSRIs): heightened gastrointestinal bleeding risk. - Other NSAIDs or COX‑2 inhibitors: additive toxicity. - Lithium: reduced renal clearance leading to toxicity. - Methotrexate: decreased renal elimination, possible toxicity.

Moderate Interactions (Monitor Closely): - ACE inhibitors or ARBs: may reduce renal function, monitor creatinine. - Diuretics: risk of renal impairment, monitor electrolytes. - Corticosteroids: increased ulcer risk, consider gastroprotection.